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miR-9-1 gene methylation and 
DNMT3B (rs2424913) polymorphism 
may contribute to periodontitis
Genetic and epigenetic changes have been associated with periodontitis 
in various genes; however, little is known about genes involved in epigenetic 
mechanisms and in oxidative stress. Objective: This study aims to investigate 
the association of polymorphisms C677T in MTHFR (rs1801133) and -149C→T 
in DNMT3B (rs2424913), as well as the methylation profiles of MTHFR, 
miR-9-1, miR-9-3, SOD1, and CAT with periodontitis. The association 
between polymorphisms and DNA methylation profiles was also analyzed. 
Methodology: The population studied was composed of 100 nonsmokers 
of both sexes, divided into healthy and periodontitis groups. Genomic DNA 
was extracted from the epithelial buccal cells, which were collected through 
a mouthwash. Polymorphism analysis was performed through polymerase 
chain reaction-restriction fragment length polymorphism (PCR-RFLP), while 
methylation-specific PCR (MSP) or combined bisulfite restriction analysis 
techniques were applied for methylation analysis. Results: For DNMT3B, 
the T allele and the TT genotype were detected more frequently in the 
periodontitis group, as well as the methylated profile on the miR-9-1 promoter 
region. There was also a tendency towards promoter region methylation on 
the CAT sequence of individuals with periodontal disease. Conclusion: The 
polymorphism -149C→T in DNMT3B (rs2424913) and the methylated profile 
of the miR-9-1 promoter region are associated with periodontitis. 
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Introduction
Periodontitis is defined as a chronic, inflammatory, 
and multifactorial disease; it is associated with a 
dysbiotic biofilm and characterized by the progressive 
destruction of the dental insertion apparatus.1 
Epidemiological studies revealed that most adult 
individuals are affected by mild and moderate forms 
of this disease, while 5-20% of any population has 
severe periodontitis. In Brazil, the periodontitis 
prevalence is higher than the global average.2 If not 
treated, periodontitis is a risk factor for prominent 
noncommunicable diseases, including pneumonia, 
gastritis, diabetes mellitus, and chronic renal 
disorders; also, the number of lost teeth is predictive 
of mortality by cardiovascular conditions.3
As a multi factorial disease, genetic and 
environmental aspects are important factors that lead 
to the susceptibility to periodontitis. Environmental 
factors may alter the cellular epigenome, which may 
affect gene expression. The epigenome refers to 
chemical modifications that may occur on DNA and 
histones, and to the individual’s non-coding RNA 
profile.4 Epigenetic marks comprise DNA methylation, 
chemical alterations on histones (methylation, 
acetylation, and phosphorylation), and small, non-
coding RNA (microRNA). 
DNA methylation occurs in the CpG dinucleotides, 
mainly in gene promoter regions, and controls 
expression at the transcriptional level by hindering 
the access of transcription factors to their binding 
sites. Methyl radicals are added to the DNA by DNA 
methyltransferases (DNMT), and these enzymes use 
the S-adenosyl methionine (SAM) radical as substrate. 
The SAM molecules are synthesized during the folate 
metabolic pathway by the methylenetetrahydrofolate 
reductase (MTHFR) activity. MicroRNAs, in turn, control 
the gene expression at the post-transcriptional level 
by biding to target messenger RNA (mRNA) and 
inhibiting their translation. Approximately 50% of the 
microRNA genes are associated with CpG islands, and 
their expression may be regulated by DNA methylation 
pathways.5 
Genetic polymorphisms in MTHFR and DNMT may 
influence the DNA methylation profile; as mentioned, 
these enzymes originate the SAM radical and use it 
as substrate for DNA methylation, respectively. The 
polymorphism C677T MTHFR (rs1801133) reduces 
enzymatic activity, resulting in a decrease in SAM 
concentration. The polymorphism -149C→T DNMT3B 
(rs2424913), on the other hand, enhances the 
transcription of the sequence.6 In fact, some studies 
demonstrated that rs1801133 is associated with global 
and site-specific hypomethylation,7 while rs2424913 is 
associated with hypermethylation of specific genes.8
DNA methylation profile alterations have been 
described in periodontitis, especially in Toll-like 
receptor, cytokine, and metalloproteinase genes.9,10 
Notably, some of these studies reported epigenetic 
alterations outside of gingival tissue, such as buccal 
epithelium and blood. This phenomenon may suggest 
these changes are not limited to the gingiva and, at the 
same time, reflect the cellular condition. Information on 
the methylation profile of microRNA genes (miR) and 
on the genes involved in the oxidative stress pathway 
are still scarce. However, the microRNA expression 
as well as antioxidant proteins, such as superoxide 
dismutase and catalase, are altered in periodontitis 
patients’ gingival tissue cells and saliva.11,12
It speculated that genetic polymorphisms in DNA 
methylation pathway genes (MTHFR and DNMT) and 
methylation profile alterations in microRNA genes 
and in genes from the oxidative stress pathway may 
be involved in periodontitis pathogenesis. This study 
focused on these genes because, as mentioned earlier, 
MTHFR and DNMT are involved in DNA methylation 
processes and both polymorphisms and methylation of 
these genes are involved in inflammatory diseases,13-15 
probably affecting the levels of products originated 
during the folate metabolic cycle, such as homocysteine 
and SAM radicals.7 Genes related to oxidative stress 
pathways, such as SOD and CAT, have been associated 
with periodontitis,12 while microRNA genes are 
involved in inflammatory diseases by silencing several 
mRNA targets related to cellular processes, including 
cellular homeostasis, proliferation, differentiation, 
development, growth, and apoptosis,11 particularly 
the miR-9 family targets transcripts of inflammatory 
cytokines.16,17 However, to the best of our knowledge, 
nothing is known, in the context of periodontitis, about 
genetic and epigenetic marks in the above genes.
Therefore, the main objective of this study 
was to investigate the association between the 
MTHFR rs1801133 and the DNMT3B rs2424913 
polymorphisms, and methylation profiles from MTHFR, 
miR-9-1, miR-9-3, superoxide dismutase (SOD1), 
and catalase (CAT) genes with periodontitis. The 
study also assessed the association between these 
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polymorphisms, the DNA methylation profiles, and 
periodontitis. 
Methodology
Studied population and research ethics
The study was conducted according to the Declaration 
of Helsinki and was approved by the Research Ethics 
Committee (CAAE: 64578717.4.0000.5188). A 
convenience sample of unrelated nonsmoking subjects 
(30-70 years old) was recruited for this study from 
the patient pool of the Periodontics Clinic (Department 
of Clinical and Social Odontology) from May 2017 to 
November 2018. The studied population from the 
Northeast region of Brazil comprised 100 individuals 
of both sexes who were generally healthy; their 
diagnosis was based on the American Academy of 
Periodontology guidelines.18 The medical and dental 
history were recorded including the measurements of 
probing depth (PD), bleeding on probing, and clinical 
attachment level (CAL) at six sites per tooth. Following 
the diagnosis, the participants were divided into two 
groups according to the coauthor’s supervision: the 
control group (n=50), which included individuals with 
no clinical signs of gingival inflammation, with CAL 
and PD <3 mm; and the chronic periodontitis group 
(n=50), comprising patients with at least 3 teeth 
presenting CAL and PD >5 mm and clinical signs of 
inflammation. Exclusion criteria for this study included 
smoking, diabetes, history of periodontal treatment, 
pregnancy, hepatitis, HIV infection, and use of anti-
inflammatory medication in the last 6 months.
Sample collection and DNA extraction
Buccal mucosa cells were collected from a one-
minute mouthwash with 6 mL of autoclaved dextrose 
(3%), and after the collection 3 mL of TNE buffer was 
added. The samples were taken to the Laboratory 
of Molecular Genetics (Department of Molecular 
Biology), where nucleic acid extraction and molecular 
analysis were performed. Subsequently, the samples 
were centrifuged at 3,000 rpm for 10 min and the 
supernatant was discarded. Lysis solution was added 
to the pelleted epithelial cells and the samples were 
stored at -20ºC until DNA extraction. The genomic 
DNA was purified with 8 M ammonium acetate.19 
The amount and the purity of the isolated DNA were 
measured with a Nanodrop spectrophotometer using 
the OD 260/280 ratio. The sample was considered 
pure when the mean value between two readings was 
1.8 or greater.
 
Genetic polymorphism analysis of MTHFR and 
DNMT3B 
The analysis of the single nucleotide polymorphisms 
(SNPs) C677T MTHFR (rs1801133) and -149C→T 
DNMT3B (rs2424913) was performed through 
polymerase chain reaction–restriction fragment length 
polymorphism (PCR-RFLP), where DNA fragments are 
amplified by PCR and digested by a restriction enzyme. 
The presence or absence of the SNP was obtained 
according to the restriction enzyme activity. The 15-
µL reactions contained 7.5 μL GoTaq® G2 Hot Start 
Green Master Mix (Promega), 1 μL of each primer (10 
μM), 1 μL of DNA, and nuclease-free water. PCR and 
enzymatic digestion conditions, as well as the chosen 
primers, were previously described.15,16,20,21 Genotypes 
were analyzed through vertical electrophoresis in 6% 
polyacrylamide gels, followed by coloring with silver 
nitrate or GelRed® (Biotium). The 677 CC/CT/TT and 
the -149 CC/CT/TT genotypes were identified by their 
band pattern according to the literature.15,16,20,21 
Methylation analysis of MTHFR, miR-9-1, and 
miR-9-3 gene promoters
Analysis of MTHFR, miR-9-1, and miR-9-3 promoter 
methylation was performed using the methylation-
specific PCR (MSP). To perform this technique, the 
purified DNA was transformed with sodium bisulfite 
and with hydroquinone for 3 h at 70°C for complete 
unmethylated cytosine conversion into uracil. The 
differences in the DNA sequences after the bisulfite 
treatment were detected by amplification with 
specific primers for methylated and non-methylated 
sequences, as previously described. The PCR conditions 
were also previously described.22,23 After amplification, 
the methylation profiles were visualized through 
vertical electrophoresis of 7 µl of amplified DNA in 
6% polyacrylamide gels, followed by silver nitrate 
coloring. The profiles were categorized as methylated, 
with amplification for the methylated condition 
only; unmethylated, with amplification for the non-
methylated condition; and partially methylated, when 
amplification was observed for both conditions.
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Methylation analysis of SOD1 and CAT gene 
promoters
SOD1 and CAT promoter methylation analysis 
was performed using combined bisulfite restriction 
analysis (COBRA), in which the DNA is submitted to 
a bisulfite treatment followed by a PCR amplification, 
and enzymatic digestion with restriction enzymes 
specific for transformed (C→U) or conserved CpG 
sites.24 The DNA was transformed as previously 
mentioned. The primer sequences for each gene 
(CAT: F:5’-GTTTTAATTGTTGAGTAATAAATGAGA-3’ and 
R:5’-AAAAAAAACAACCTTCTTTTCA-3’, 199 base pairs 
(bp); SOD1: F:5’-GGTTTTTTAATTGTTGGGTTAGAG-3’ 
and R:5’- ACTCAACCAATCAACACCAC-3’, 175 bp) 
were obtained using the Methyl Primer Express 
v1.0 (Applied Biosystems) software according to 
the promoter region sequence entered into the 
Genome Browser (chr21:31,659,622-31,668,931 and 
chr11:34,438,925-34,472,062, respectively). Fifteen 
µL reactions contained 7.5 µL GoTaq® Hot Start Green 
Master Mix (1X; Promega), 2 µL of the primer sets 
(10 µM), 5 µL (~100 ng) of transformed DNA, and 
nuclease-free water. Forty-cycle amplifications were 
performed for both sequences. For CAT, the annealing 
temperature was 55°C, while for SOD it was 51°C.
After amplification, 3 µL of the PCR products 
were digested by the restriction enzyme AciI (GCGG; 
Thermo Fisher) for 3 h at 37°C, followed by vertical 
electrophoresis in a 6% polyacrylamide gel, and 
coloring with GelRed®. Methylation profiles were 
categorized as methylated or with enzymatic digestion 
when the GCGG sites were not transformed during 
treatment; unmethylated or without enzymatic 
digestion when the GCGG sites were transformed 
during the treatment; and partially methylated or 
with partial digestion. To ensure specificity of all 
methylation protocols, completely methylated and 
demethylated DNA controls were used (Cells-to-CpG™ 
Methylated & Unmethylated gDNA Control Kit, Life 
Technologies). 
Statistical analysis
All data were compiled in an Excel® spreadsheet. 
Descriptive statistics was used for demographic data. 
The Hardy-Weinberg equilibrium (HWE) was calculated 
for each polymorphism using the chi-squared test. 
The Fisher’s Exact or the chi-squared tests were also 
used for the analysis of possible associations between 
genotypic frequencies, allelic frequencies, methylation 
profiles, and the outcome (periodontitis), as well as 
the association between the methylation profiles and 
the presence of polymorphisms. All analyses were 
performed using the BioEstat 5.3 software. p-values 
<0.05 were considered statistically significant.
Results
Demographic data are shown in Table 1. 
Genetic polymorphism analysis
Table 1 shows the genotypic and allelic distributions 
in the population studied. Both groups are in 
accordance with the HWE for each of the polymorphisms 
studied (DNMT3B (rs2424913): control, p=0.35 and 
periodontitis, p=0.78; MTHFR (rs1801133): control, 
p=0.31 and periodontitis, p=0.16). For DNMT3B, the 
T allele was more frequent in the periodontitis (52%) 
compared with the control group (33%; p=0.01). 
The same trend was observed for the TT genotype, 
which was more frequent in the periodontitis (28%) 
compared with the control group (8%; p=0.01). 
Individuals with the TT genotype are approximately 
four times more likely to develop periodontitis [OR: 
4.47 (1.35;14.75)]. For MTHFR, the C allele and the 
genotypes CC and CT were the most common in both 
groups; therefore, no significant differences were 
observed between the groups (Table 1 and Figure 1).
Methylation profile analysis
For MTHFR, the unmethylated profile appeared 
more frequently in both groups (92.5% in the 
control group and 90% in the periodontitis group). 
For miR-9-1, methylation occurred in 100% of the 
periodontitis patients but only in 77.5% of the control 
group participants (p=0.0024). On the other hand, 
miR-9-3 showed a partially methylated profile in both 
groups (100%; Table 1 and Figure 2). For SOD1, 
the unmethylated profile was the most frequent in 
both groups (85% of the control group and 79% 
of the periodontitis group). For CAT, although no 
significant difference was observed between the two 
groups, there was a tendency towards methylation 
in the periodontitis group, since the methylated 
profile was more common amongst these patients 
(55%=50% partially methylated +5% methylated) 
when compared with the control group (42.5%=40% 
partially methylated +2.5% methylated; p=0.077; 
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Table 1 and Figure 3). The DNMT3B TT genotype and 
the miR-9-1 methylation profile were considered for 
statistical association analysis, because both genes 
showed a statistically significant difference between 
the two groups. However, no association between 
these variables and periodontitis was found. 
Discussion
Periodontitis has been associated with genetic 
polymorphisms in several cellular pathways.25 From 
2009 onwards,9 methylation analysis studies in 
the context of periodontal disease have markedly 
increased; however, many genes still need to be 
Demography Control
(n=50)
Periodontitis (n=50) P value
Age (years) 38.7 (±7.5) 49.0 (±11.3) 0.0001
% men 12 22 0.001
% women 38 28
Probing depth (mm) ≤ 3 ≥ 5
Polymorphism n= 50 n= 50
DNMT3B genotype
CC 21 (42%) 12 (24%) 0.01*
CT 25 (50%) 24 (48%) OR:4.47;
TT 04 (08%) 14 (28%) [1.35;14.75]
Allele frequency %
C 67 48 0.01*
T 33 52 OR: 2.19; 
MTHFR genotype
CC 26 (52%) 21 (42%)
CT 18 (36%) 26 (52%) >0.05
TT 06 (12%) 03 (06%)
Allelle frequency %




M 01 (2.5%) 0 (0%)
U 37 (92.5%) 36 (90%) >0.05
M and U 02 (5%) 04 (10%)
miR-9-1 n= 40 n=40
M and U 31 (77.5%) 40 (100%) 0.0024#
U 09 (22.5%) 0 RR:1.29; [1.09;1.52]
miR-9-3 
M and U 40 (100%) 40 (100%) >0.05
U 0 0
SOD1 n= 40 n= 38
M 0 0
U 34 (85%) 30 (79%) >0.05
M and U 06 (15%) 08 (21%)
CAT n =40 n=40
M 01 (2.5%) 02 (5%)
U   23 (57.5%) 18 (45%) 0.077#
M and U 16 (40%) 20 (50%)
M= methylated, U= unmethylated, M and U= partially methylated * Fisher's exact, #χ2 Test.
Table 1- Demographic, polymorphism, and DNA methylation data
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analyzed. This study focused on the genes that had 
not been previously studied in polymorphism or 
in methylation contexts, and are involved in DNA 
methylation (MTHFR and DNMT3B), oxidative stress 
(SOD1 and CAT), and translation inhibition (non-
coding miR-9-1 and miR-9-3).
The population studied showed the TT genotype 
and the T allele for DNMT3B was more frequent 
in individuals with periodontitis. This gene is part 
of the DNA methyltransferase gene family, which 
acts by transferring the methyl radical (CH3) to 
DNA molecules with no previous methylation marks 
(de novo methylation). The C→T exchange in the 
promoter region enhances its own transcription and 
possibly causes a predisposition to abnormal de novo 
methylation and to transcription inhibition.26 Based 
on this possibility, the TT genotype could lead to 
hypermethylation and further silencing of important 
genes related to the protection against periodontitis. 
The homozygous TT genotype for the DNMT3B 
rs2424913 had already been previously associated 
with head and neck squamous cell carcinoma,21,27 
while the CT genotype was associated with oral 
lichen planus and with an increase in expression of 
the protein encoded by this genotype.15 DNMT3B has 
been minimally explored in the periodontitis context 
and a recent study demonstrated that its expression 
increases after the administration of Porphyromonas 
gingivalis in experimental periodontitis.28 
The MTHFR rs1801133 polymorphism showed 
no association with periodontitis. The C allele and 
the genotypes CC and CT were the most frequent 
in the entire population studied. The T allele and 
the TT genotype have been associated with other 
oral disease contexts, including lichen planus and 
squamous cell carcinoma.29,30 The enzyme encoded 
by this gene participates in the folate metabolism 
pathway, which produces the SAM radicals used by 
the DNMTs as methyl donors for DNA methylation. 
The C→T exchange reduces enzymatic activity and 
possibly leads to DNA hypomethylation.
In this study, the unmethylated MTHFR profile 
was recurrent among all participants. A previous 
study on MTHFR methylation in the buccal mucosa 
also identified the unmethylated profile as the most 
frequent amongst both young and elderly individuals.31 
Figure 1- Representative bands of MTHFR and DNMT3B stained with silver nitrate or GelRed® following the PCR-RFLP method for both 
control and periodontitis groups. (A) Amplicons for the MTHFR SNP in exon: CC=198 bp, CT=198, 175 and 23 bp (not shown), TT=175 
and 23 bp (not shown); (B) Amplicons for the DNMT3B SNP in gene promoter: CC=230 bp, CT=230, 172 and 58 bp (not shown), TT=172 
and 58 bp (not shown). P1-P6=patient 1–patient 6
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These data collectively demonstrate that this profile is 
common in buccal epithelial cells and is not associated 
with oral inflammation. The same CpG site analyzed 
herein has been studied by our group in patients with 
diabetic complications; the hypermethylated profile 
was detected in blood.14
The data of this study concerning promoter 
methylation in microRNA genes revealed that the 
partially methylated miR-9-3 condition was the 
standard profile for buccal epithelial cells in individuals 
with or without periodontitis, while the miR-9-1 
methylation was more common in periodontitis 
patients. According to definitions found in a microRNA 
database (http://www.mirdb.org), all three loci for 
miR-9 genes (1, 2 and 3) in the human genome can 
be transcribed into the same mature miR-9 sequence. 
The miRDB database shows miR-9 may have 991 
predictive targets. Hypermethylation of these genes 
and a decrease in their own expression may increase 
the levels of such targets, as has been recently shown 
by Marinho, et al.32 (2019). In this study, levels of 
the rap guanine nucleotide exchange factor, a miR-
9 target, were higher in the periodontitis patients’ 
gingival crevicular fluid. The signaling cascade in which 
this factor participates may be involved in apoptosis, 
integrin-mediated signal transduction, and cellular 
transformation. Another target, the transforming 
growth factor β-1 (TGF-β1) receptor, is also expressed 
in the gingival tissue of individuals with periodontal 
disease.16 It binds to the anti-inflammatory cytokine 
TGF-β1, which is involved in tissue regeneration and 
cellular processes such as proliferation, growth, and 
differentiation. 
miR-9-1 hypermethylation has also been observed 
in cervical and ovarian cancer, and myeloma.17,33,34 
A study with HeLa cells demonstrated that miR-
9 hypermethylation reduces its expression and is 
associated with enhanced interleukin 6 (IL-6) levels, 
a finding that may indicate that IL-6 transcripts are 
targets for miR-917. Interleukin 6 levels are higher in 
Figure 2- Representative bands of MTHFR and miR-9 stained with silver nitrate following amplification by MSP method for both control 
and periodontitis groups. (A) Amplicons for methylated and unmethylated (198 bp) status of the MTHFR gene promoter; (B) Amplicons 
for methylated and unmethylated (110 bp) status of the miR-9-1 gene promoter; (C) Amplicons for methylated and unmethylated (116 bp) 
status of the miR-9-3 gene promoter. M=methylated, U=unmethylated. P1-P6=patient 1–patient 6.
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periodontitis patients when compared with those of 
control groups.35
The partially methylated miR-9-3 condition, in 
which not all cells present methylation marks in 
the same CpG sites, had been previously observed 
for epithelial buccal cells of nonsmoker individuals, 
reassuring that partial methylation is the common 
profile for these cells.22
Regarding CAT and SOD1 genes, CpG sites were 
chosen due to their location, because they are 
immersed in a CpG island near the gene promoter and 
act as recognition sites for restriction enzymes used 
in the COBRA technique. Sites -47 for CAT and -184 
for SOD1 have affinity for the Sp1 transcription factor, 
which positively controls transcription for these genes. 
This feature may suggest that both sites contribute to 
regulating each sequence’s expression.36,37
Catalase and superoxide dismutase, the enzymes 
that are encoded by CAT and SOD1, respectively, are 
part of the human enzymatic antioxidant defense 
group that protects against oxidative damage derived 
from the reactive oxygen species (ROS). Thus, these 
enzymes modulate the extension of inflammatory 
reactions. Both enzyme levels have been evaluated 
in various contexts and many studies demonstrated 
a strong association between oxidative stress and 
periodontal disease. Most researches in this field 
evaluated transcript levels, protein expression, 
antioxidant enzymatic activity, total antioxidant 
capacity, and ROS levels.12 Nevertheless, methylation 
profile studies are scarce, and nothing was known 
about periodontitis patients. 
For SOD1, the unmethylated profile was the 
most frequent for CpG site -184 in the entire studied 
population, indicating that this profile is standard 
for buccal epithelial cells. Similar to this study, an 
unmethylated profile for various SOD1 promoter 
region CpG sites occurs in the cerebral cortex and 
blood cells in lateral amyotrophic sclerosis patients, 
as well as in the control individuals.38 Although the 
SOD1 is generally considered to be a maintenance 
gene due to its ubiquitous and abundant expression, 
this induction of sequence is finely controlled by 
complex intracellular events. Alterations in the SOD1 
expression have been linked to periodontitis, however, 
data are still inconclusive, since some studies report 
increase in the SOD expression/activity while others 
indicate decline.12,39 Considering that gene expression 
Figure 3- Representative bands stained with Gel Red of SOD1 and CAT following the COBRA method for both control and periodontitis 
groups. (A) Amplicons after digestion for methylated (139 bp) and unmethylated (175 bp) status of the SOD1 gene promoter; (B) Amplicons 
after digestion for methylated (167 bp) and unmethylated (199 bp) status of the CAT gene promoter. P1-P6=patient 1–patient 6.
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may be controlled by DNA methylation, it is important 
to consider methylation studies on SOD1 and 
periodontitis. If the analysis of this study had involved 
inflammation sites, such as SOD expression studies, 
some associations could have been detected. In any 
case, this study infers that the unmethylated profile at 
site -184 in SOD1 is common for buccal epithelial cells 
and is not associated with periodontal inflammation. 
For CpG site -47 in CAT, there was no significant 
difference between the groups, but the periodontitis 
group profile showed a tendency towards methylation. 
It has been demonstrated that methylated CpG sites 
near the CAT promoter region are associated with 
catalase transcription and expression decline in liver 
tumor cell lines and tumor tissues.40 The adverse 
effects of the CAT promoter methylation upon gene 
expression have also been reported in studies with 
hepatic cell lines treated with CuO nanoparticles.40 
Catalase level reductions were detected in saliva 
of individuals with periodontitis when compared to 
healthy individuals41. This decline may be associated 
with gene methylation, which was a trend in the 
periodontitis group in this study. Additionally, the CAT 
hypermethylation observed by Punj, et al.42 (2017) 
occurred via ROS. Periodontal pathogens activate 
the host’s defenses towards ROS formation, which in 
turn, contributes to the biofilm microorganisms’ death. 
However, prolonged exposure to the ROS may induce 
a wide range of pathological reactions in the host’s 
tissue, such as membrane lysis, nuclear fragmentation, 
and enzymatic activation or inactivation. These 
changes are likely to play a role in the pathogenesis 
of many inflammatory diseases, from periodontitis 
to systemic disorders.42 Thus, the trend towards 
methylation demonstrated in this study possibly 
derives from ROS release of buccal mucosa cells in 
response to periodontal pathogens. This tendency 
should be investigated in gingival tissue in addition 
to ROS and catalase levels analysis.
This study limitations consist of a low sample size 
for polymorphism studies due to a narrow sample 
collection period and to well-defined inclusion criteria, 
and for these reasons, data on the periodontitis group 
was not subgrouped by disease severity. However, 
the data of the study referred to the DNMT3B 
polymorphism rs2424913, which had not been 
previously studied in the periodontitis context. The 
finding of this study should be further explored in 
larger populations with different ethnic backgrounds 
before any conclusions can be drawn about the role 
of this gene in periodontitis. Although this study on 
DNA methylation did not involve the inflammation 
site, it still showed that profile alterations in buccal 
mucosa cells, especially in miR-9-1, may be involved 
in periodontitis. 
As a multifactorial disease, periodontitis should 
be investigated focusing on an individual’s genetic 
and epigenetic aspects. The latter can be modulated 
by individual habits and even be considered as 
therapeutic targets. Therefore, the data of this 
study contribute to the elucidation of molecular 
mechanisms involved in periodontitis development. 
Aside from cytokine genes, Toll-like receptors, matrix 
metalloproteinases, and other molecules mentioned 
in the literature, it demonstrated that genes involved 
in DNA methylation and translation inhibition may 
be involved in periodontitis. Molecular data can be 
collectively tabulated into a panel of genes indicating 
susceptibility to periodontal disease and be used as a 
tool for personalized medicine, contributing to better 
diagnosis, prognosis, and treatment. 
In summary, the conclusion is that the genotype 
TT DNMT3B (rs2424913) and the methylated profile 
of the miR-9-1 promoter region are associated with 
periodontitis. The miR-9-1 promoter methylation yields 
a relative risk of 1.29 for periodontitis development, 
while a promoter region polymorphism in the DNMT3B 
causes individuals to be even 4 times more susceptible 
to periodontal disease.
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